Latest news
Novo Nordisk CFO Knudsen: Oral Wegovy Drives Market Expansion With 80% of Patients New to Obesity Drugs - finance.biggo.comfinance.biggo.com · Fri, 07 Aug 2026 15:09:00 GMT‘It’s been a roller coaster’: Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth - Fierce BiotechFierce Biotech · Fri, 07 Aug 2026 13:08:00 GMTThe Oral GLP-1 Tracker: Lilly's Foundayo builds scripts after disappointing Q2 - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 07:00:00 GMTResmed says weight-loss pills are driving sleep device demand - AFRAFR · Fri, 07 Aug 2026 02:46:00 GMTLilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo - 93.3 The Drive93.3 The Drive · Thu, 06 Aug 2026 04:36:48 GMTNovo Nordisk (Q2 Results): GLP-1 momentum drives an upgrade - Hargreaves LansdownHargreaves Lansdown · Wed, 05 Aug 2026 10:01:09 GMTNovo outlook hike falls flat as Wegovy pill sales fail to impress - 93.3 The Drive93.3 The Drive · Wed, 05 Aug 2026 09:09:37 GMTNovo's upbeat forecast can't overcome disappointments from oral Wegovy, CagriSema - FirstWord PharmaFirstWord Pharma · Wed, 05 Aug 2026 08:06:57 GMT